Digital health startup Ro now prescribes recently approved weight loss drug Zepbound

A dig­i­tal health start­up is jump­ing in to of­fer the lat­est weight loss drug ap­proved by the FDA.

Ro, a start­up that pre­scribes and ships med­ica­tion di­rect­ly to cus­tomers, is adding tirzepatide to its list of weight loss med­ica­tion of­fer­ings, the com­pa­ny an­nounced on Wednes­day. The Eli Lil­ly drug was ap­proved for weight man­age­ment last month with the mar­ket­ing name Zep­bound.

“Zep­bound is poised to be the most im­pact­ful an­ti-obe­si­ty med­ica­tion we’ve seen so far in our life­time,” Ro’s chief med­ical of­fi­cer Dr. Melyn­da Barnes said in a state­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.